Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Michaelsen SR, Christensen IJ, Grunnet K, Stockhausen MT, Broholm H, Kosteljanetz M, Poulsen HS.

BMC Cancer. 2013 Sep 3;13:402. doi: 10.1186/1471-2407-13-402.

PMID:
24004722
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.

Shchors K, Persson AI, Rostker F, Tihan T, Lyubynska N, Li N, Swigart LB, Berger MS, Hanahan D, Weiss WA, Evan GI.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1480-9. doi: 10.1073/pnas.1219142110. Epub 2013 Mar 29.

PMID:
23542378
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma.

Yamaki T, Suenaga Y, Iuchi T, Alagu J, Takatori A, Itami M, Araki A, Ohira M, Inoue M, Kageyama H, Yokoi S, Saeki N, Nakagawara A.

Sci Rep. 2013;3:1160. doi: 10.1038/srep01160. Epub 2013 Jan 29.

PMID:
23362460
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR.

J Hepatol. 2013 Apr;58(4):785-91. doi: 10.1016/j.jhep.2012.11.042. Epub 2012 Dec 2.

PMID:
23211317
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Integrins and p53 pathways in glioblastoma resistance to temozolomide.

Martin S, Janouskova H, Dontenwill M.

Front Oncol. 2012 Oct 31;2:157. doi: 10.3389/fonc.2012.00157. eCollection 2012.

PMID:
23120745
[PubMed]
Free PMC Article
6.

Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.

Carlson BL, Pokorny JL, Schroeder MA, Sarkaria JN.

Curr Protoc Pharmacol. 2011 Mar;Chapter 14:Unit 14.16. doi: 10.1002/0471141755.ph1416s52.

PMID:
21743824
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Kroeger KM, Muhammad AK, Baker GJ, Assi H, Wibowo MK, Xiong W, Yagiz K, Candolfi M, Lowenstein PR, Castro MG.

Discov Med. 2010 Oct;10(53):293-304. Review.

PMID:
21034670
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

Carlson BL, Grogan PT, Mladek AC, Schroeder MA, Kitange GJ, Decker PA, Giannini C, Wu W, Ballman KA, James CD, Sarkaria JN.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):212-9. doi: 10.1016/j.ijrobp.2009.04.026.

PMID:
19695438
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Targeted therapy for malignant glioma patients: lessons learned and the road ahead.

Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS.

Neurotherapeutics. 2009 Jul;6(3):500-12. doi: 10.1016/j.nurt.2009.04.008. Review.

PMID:
19560740
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk